CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing ...
CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing ...
Stay updated with breaking news from Peter Choo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing ...
CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based allogeneic immunotherapies for the treatment of various cancers, today announced that its exclusively licensed induced pluripotent stem cell (iPSC)-based technology has been granted a patent by the China National Intellectual Property Administration (CNIPA).
(RTTNews) - CytoMed Therapeutics Limited (GDTC) said its exclusively licensed induced pluripotent stem cell-based technology has been granted a pa...
/PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its...
West Seattle news, 24/7